Intravenous Solutions Market, by Solution, by Bag Type, by Application, by End User, and by Region Size, Share, Outlook, and Opportunity Analysis, 2024

Description

Global intravenous solutions market is estimated to be valued at USD 11.04 Bn in 2024 and is expected to exhibit a CAGR of 6.1% during the forecast period (2024-2031).

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 11.04 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	6.10%	2030/2031 Value Projection:	US$ 16.69 Bn

Global Intravenous Solutions Market Value (US$ Bn), by Region, 2024

Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation. These fluids are sterile, non-pyrogenic solutions used for fluid replenishment and caloric supply in single dose container for intravenous administration. There are various types of intravenous solutions available in the market such as sodium chloride, lactated ringers, dextrose in water, and others. Intravenous therapy is ideal for patients suffering from nutritional deficiency and dehydration. Dehydration can contribute to various affects such as

Balance of important minerals (electrolytes) in the body.
Cognitive (mental) performance.
Energy level.
Gastrointestinal function (your ability to digest food and create pee and poop).
Headache frequency and intensity.
Physical performance.
Skin health.

Market Dynamics

Increasing prevalence of diarrhoea is expected to boost the global intravenous solution market growth over the forecast period. For instance, in July 2022, UNICEF (United Nations International Children's Emergency Fund), an agency of the United Nations responsible for providing humanitarian and developmental aid to children worldwide, published a report which accounted for 9 per cent of all deaths among children under age 5 worldwide in 2019 due to Diarrhoea, whereas over 1,300 young children dying each day, or about 484,000 children a year globally due to diarrhoea.

Moreover, according to an article published in the Lancet Infectious Diseases, September 2018, diarrhoea was the third leading cause of disability-adjusted life year (DALYs) in 2016, which accounted for 74.4 million DALYs, globally. According to the same source, diarrhoea was the eighth leading cause of death, which accounted for 1,655,944 deaths in 2016 globally.

Key features of the study:

This report provides an in-depth analysis of the global intravenous solutions market, market size (US$ Bn), and compound annual growth rate (CAGR (%)) for the forecast period: 2024 - 2031, considering 2023 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global intravenous solutions market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include, Baxter International Inc. ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited, Pfizer, Inc, Otsuka Pharmaceutical Co., Ltd, Ajinomoto Co., Inc., B. Braun Melsungen AG, Soxa Formulations & Research Pvt.Ltd, Sichuan Kelun Pharmaceutical Co Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global intravenous solutions market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global intravenous solutions market.

Detailed Segmentation:

Global Intravenous Solutions Market, By Solution type:
- Saline
- Normal Saline (0.9% NaCl)
- Hypertonic Saline
- Dextran
- Lactated Ringer's
- Amino Acid
- Vitamins & Minerals
- Heparin and Trace Elements
- Mixed Solutions
Global Intravenous Solutions Market, By Bag type:
- Large Volume Bags (greater than 250ml)
- Small Volume Bags (less than 250ml)
Global Intravenous Solutions Market, By Application:
- Basic IV Solution
- Nutritional IV Solution
- Blood IV Solution
- Drug IV Solution
- Irrigation IV Solution
Global Intravenous Solutions Market, By End User:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Home Care Settings
Global Intravenous Solutions Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Baxter International Inc.
- ICU Medical, Inc.
- Braun Melsungen Ag
- Grifols, S.A.
- Fresenius Kabi USA, LLC
- Vifor Pharma Management Ltd.
- JW Life Science
- Amanta Healthcare
- Axa Parenterals Ltd.
- Salius Pharma Private Limited.
- Pfizer, Inc.
- Otsuka Pharmaceutical Co., Ltd
- Ajinomoto Co., Inc.
- Braun Melsungen AG
- Soxa Formulations & Research Pvt.Ltd
- Sichuan Kelun Pharmaceutical Co Ltd

Product Code: CMI1134

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Solution
- Market Snapshot, By Bag Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Epidemiology
Porter's Five Forces Analysis

4. Global Intravenous Solutions Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
COVID-19 Impact on the market

5. Global Intravenous Solutions Market, By Solution, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Saline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Normal Saline (0.9% NaCl)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Hypertonic Saline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Dextran
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Lactated Ringer's
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Amino Acid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Vitamins & Minerals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Heparin and trace elements
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Mixed Solutions
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

6. Global Intravenous Solutions Market, By Bag Type, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Large Volume Bags (greater than 250ml)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Small Volume Bags (less than 250ml)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

7. Global Intravenous Solutions Market, By Application, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Basic IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Nutritional IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Blood IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Drug IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Irrigation IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

8. Global Intravenous Solutions Market, By End User, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Ambulatory Surgery Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Home care Settings
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

9. Global Intravenous Solutions Market, By Region, 2019 - 2031, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Solution, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Solution, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
GCC
Israel
Rest of Middle East
Africa
North Africa
Central Africa
South Africa

10. Competitive Landscape

Heat Map Analysis
Company Profile
- Baxter International Inc.
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- ICU Medical, Inc.
- B. Braun Melsungen Ag
- Grifols, S.A
- Fresenius Kabi USA, LLC
- Vifor Pharma Management Ltd.
- JW Life Science
- Amanta Healthcare
- Axa Parenterals Ltd
- Salius Pharma Private Limited.
- Pfizer, Inc.
- Otsuka Pharmaceutical Co., Ltd
- Ajinomoto Co., Inc.
- Braun Melsungen AG
- Soxa Formulations & Research Pvt. Ltd
- Sichuan Kelun Pharmaceutical Co Ltd

11. Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. Section

References
Research Methodology
About Us and Sales Contact

Intravenous Solutions Market, by Solution, by Bag Type, by Application, by End User, and by Region Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031